相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
Bryan H. Burmeister et al.
LANCET ONCOLOGY (2012)
An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection
Matthew Foote et al.
MELANOMA RESEARCH (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study
P. Quaglino et al.
ANNALS OF ONCOLOGY (2010)
The Benefits of Adjuvant. Radiation Therapy After Therapeutic Lymphadenectomy for Clinically Advanced, High-Risk, Lymph Node-Metastatic Melanoma
Shefali Agrawal et al.
CANCER (2009)
Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
Jasper G. van den Boorn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Malignant melanoma and vitiligo: can radiotherapy shed light on the subject?
A. Abood et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2009)
Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features
Anke Hartmann et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2008)
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
F. Stephen Hodi et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Stephanie G. Downey et al.
CLINICAL CANCER RESEARCH (2007)
Vitiligo at the site of radiotherapy for nasopharyngeal carcinoma
Muhterem Polat et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2007)
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma
Peter D. Boasberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A phase II trial of tow-dose total body irradiation and subcutaneous interleukin-2 in metastatic melanoma
A Safwat et al.
RADIOTHERAPY AND ONCOLOGY (2005)
Combining radiotherapy and immunotherapy: A revived partnership
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Case 3. Vitiligo after radiotherapy for breast cancer in a woman with depigmentation disorder
R Weitzen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Autoantibodies in vitiligo patients are not directed to the melanocyte differentiation antigen MelanA/MART1
EA Waterman et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Vitiligo at the sites of irradiation in a patient with Hodgkin's disease
F Pajonk et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2002)
分享论文
